Bronchiectasis screening: Difference between revisions
Jump to navigation
Jump to search
Hamid Qazi (talk | contribs) No edit summary |
Hamid Qazi (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Bronchiectasis}} | {{Bronchiectasis}} | ||
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D. | {{CMG}}; {{AE}} {{HQ}}, Saarah T. Alkhairy, M.D. | ||
==Overview== | ==Overview== | ||
Line 15: | Line 15: | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | |||
{{ | [[Category:Primary care]] | ||
{{ | {{WH}} | ||
{{WS}} |
Revision as of 21:32, 11 February 2018
Bronchiectasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Bronchiectasis screening On the Web |
American Roentgen Ray Society Images of Bronchiectasis screening |
Risk calculators and risk factors for Bronchiectasis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2], Saarah T. Alkhairy, M.D.
Overview
There is no routine screening for bronchiectasis. If the patient has an immune deficiency or primary ciliary dyskinesia then pulmonary function tests should be measures four times a year.
Bronchiectasis Screening
- There is no routine screening for bronchiectasis.
- If the patient has an immune deficiency or primary ciliary dyskinesia, the forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and peak expiratory flow (PEF) should be measured four times a year